Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer

Official Title

Clinical and Cost-effectiveness of a Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer: the 5C Study


A multicentre two-group parallel single-blind (outcome assessor) randomized controlled trial (RCT). A cost effectiveness study alongside a clinical trial using a payer and societal perspective to study the cost-effectiveness of geriatric assessment and management compared to usual care will be conducted. Participants allocated to the control group will receive usual oncology care. Participants allocated to the intervention group will receive a comprehensive geriatric assessment and management in addition to their usual oncology care. The intervention will take 6 months to be completed. Total study follow-up will be 12 months for each participant.

Trial Description

Primary Outcome:

  • Quality of life
  • Quality of Life
Secondary Outcome:
  • Cost-effectiveness
  • Functional status
  • Functional status
  • The number of geriatric issues successfully addressed for participants in intervention group
  • Treatment toxicity
  • Unplanned health care use
  • Satisfaction
  • Satisfaction
  • Cancer treatment plan modification
  • Overall survival
  • Intervention fidelity by treatment centre

View this trial on

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society